MIM
NAMSW icon

Monashee Investment Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Monashee Investment Management’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31,189
Closed -$218K – 77
2024
Q3 		$218K Buy
+31,189
New +$242K 0.02% 108
2024
Q2 		– Sell
-31,189
Closed -$344K – 113
2024
Q1 		$344K Buy
+31,189
New +$284K 0.04% 101

Other funds holding NAMSW

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Monashee Investment Management's NAMSW Position: Q4 2024 in Review

Monashee Investment Management sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q4 2024, closing a stake of 31,189 shares — an estimated $218K sold.

Monashee Investment Management first reported a position in NAMSW in Q1 2024 and held it in 2 quarters. The position peaked at $344K in Q1 2024. 11 funds tracked by Wall St. Rank hold NAMSW as of Q4 2024.

  • Monashee Investment Management reported no remaining NewAmsterdam Pharma Warrant position as of Q4 2024 after selling out during the quarter.
  • Monashee Investment Management sold 31,189 NewAmsterdam Pharma Warrant shares in Q4 2024, an estimated $218K.
  • Monashee Investment Management first reported a position in NewAmsterdam Pharma Warrant in Q1 2024 and held it in 2 quarters.
  • Monashee Investment Management's NewAmsterdam Pharma Warrant position peaked at $344K in Q1 2024.
  • 11 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q4 2024.

Based on Monashee Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.